Document Detail


Adverse events from targeted therapies in advanced renal cell carcinoma: the impact on long-term use.
MedLine Citation:
PMID:  21251188     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
The aim of this review is to help physicians tailor targeted treatments for advanced renal cell carcinoma to suit patient needs and ensure maximum overall duration of response to therapy by providing a summary of the frequency and time of onset of adverse events (AEs) and by raising awareness of AE profiles. A PubMed literature search was performed, and papers on targeted therapy-related AEs were reviewed. The frequency, severity and management of targeted therapy-related AEs are discussed. Manageable AEs commonly reported with all the approved targeted agents include: fatigue, gastrointestinal disorders (diarrhoea, nausea, vomiting), hypertension, skin and subcutaneous tissue disorders. Life-threatening AEs are less common than manageable AEs and are usually class specific. Data suggest that long-term treatment with well-established targeted agents does not result in increased or unexpected AEs. Caution is required with regard to the long-term use of newer targeted agents for which there are no long-term tolerability data or clinical experience. Studies have reported that the type and frequency of observed AEs associated with sequential tyrosine kinase inhibitor (TKI) use are similar to those reported in the literature for TKI monotherapy. Having an awareness of the AE profiles of targeted agents allows the development of effective management strategies. Generally, more extensive clinical experience has accumulated, and AE profiles are more predictable, for well-established targeted agents.
Authors:
Ziya Kirkali
Related Documents :
18817028 - Primary cerebral angitis of the central nervous system: case report.
22232728 - Pyknodysostosis: report of a rare case with review of literature.
21772808 - Extracranial infrasellar ectopic craniopharyngioma: a case report and review of the lit...
17800428 - Voyager 1 encounter with the jovian system.
184748 - Granular cell myoblastoma of the bronchus: report of 2 cases and review of the literature.
17958718 - Dysphagia lusoria: a comprehensive review.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-1-20
Journal Detail:
Title:  BJU international     Volume:  -     ISSN:  1464-410X     ISO Abbreviation:  -     Publication Date:  2011 Jan 
Date Detail:
Created Date:  2011-1-21     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100886721     Medline TA:  BJU Int     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
© 2011 THE AUTHOR; BJU INTERNATIONAL © 2011 BJU INTERNATIONAL.
Affiliation:
Dokuz Eylul University, School of Medicine, Izmir, Turkey.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Safety and efficacy of ultrasonography as an adjunct to fluoroscopy for renal access in percutaneous...
Next Document:  Biology of the sauropod dinosaurs: the evolution of gigantism.